Exclusive

Publication

Byline

Location

US Patent Issued to Acura Pharmaceuticals on Oct. 27 for "Methods and compositions for self-regulated release of active pharmaceutical ingredient" (Maryland, Georgia Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,454, issued on Oct. 27, was assigned to Acura Pharmaceuticals Inc. (Palatine, Ill.). "Methods and compositions for self-regulated release o... Read More


US Patent Issued to AstraZeneca on Oct. 27 for "Stable, aqueous formulations of antibodies that bind IL5 receptor" (Maryland Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,455, issued on Oct. 27, was assigned to AstraZeneca AB (Sodertalje, Sweden). "Stable, aqueous formulations of antibodies that bind IL5 rece... Read More


US Patent Issued to Cella Therapeutics on Oct. 27 for "Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-Alpha (TNF-Alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,456, issued on Oct. 27, was assigned to Cella Therapeutics LLC (Miami). "Drug delivery systems comprising a neurotrophic agent, an apoptosi... Read More


US Patent Issued to SIGILON THERAPEUTICS on Oct. 27 for "Implantable devices for cell therapy and related methods" (Massachusetts, Texas, Rhode Island, Illinois Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,457, issued on Oct. 27, was assigned to SIGILON THERAPEUTICS INC. (Cambridge, Mass.). "Implantable devices for cell therapy and related met... Read More


US Patent Issued to BIOHAVEN THERAPEUTICS on Oct. 27 for "Directed conjugation technologies" (Connecticut Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,458, issued on Oct. 27, was assigned to BIOHAVEN THERAPEUTICS LTD. (New Haven, Conn.). "Directed conjugation technologies" was invented by ... Read More


US Patent Issued to Spectrum Pharmaceuticals on Oct. 27 for "Methods of treatment using g-CSF protein complex" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,459, issued on Oct. 27, was assigned to Spectrum Pharmaceuticals Inc. (Lake Forest, Ill.). "Methods of treatment using g-CSF protein comple... Read More


US Patent Issued to PAUL SCHERRER INSTITUT on Oct. 27 for "Transglutaminase conjugation method with a glycine based linker" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,460, issued on Oct. 27, was assigned to PAUL SCHERRER INSTITUT (Villigen PSI, Switzerland). "Transglutaminase conjugation method with a gly... Read More


US Patent Issued to SYSTIMMUNE on Oct. 27 for "Camptothecin drug and its antibody conjugate thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,461, issued on Oct. 27, was assigned to SYSTIMMUNE INC. (Redmond, Wash.). "Camptothecin drug and its antibody conjugate thereof" was invent... Read More


US Patent Issued to The Broad Institute on Oct. 27 for "Systems for evolved adeno-associated viruses (AAVs) for targeted delivery" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,462, issued on Oct. 27, was assigned to The Broad Institute Inc. (Cambridge, Mass.). "Systems for evolved adeno-associated viruses (AAVs) f... Read More


US Patent Issued to SciMar on Oct. 27 for "Test meal, test meal packaging, method and uses thereof" (Canadian Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,463, issued on Oct. 27, was assigned to SciMar Ltd. (Dauphin, Canada). "Test meal, test meal packaging, method and uses thereof" was invent... Read More